Precipio, Inc.

PRPO

US74019L6020

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-17 pm EDT			5-day change	1st Jan Change
6.705 ^USD	-0.45%		+0.76%	+3.15%

Apr. 01	Transcript : Precipio, Inc. - Special Call
Mar. 29	Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Precipio, Inc.

Transcript : Precipio, Inc. - Special Call	Apr. 01
Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Precipio, Inc. and Cardinal Health Sign Distribution Agreement for Its HemeScreen®? Portfolio of Molecular Assays for Cancer	Feb. 06	CI
Sector Update: Health Care Stocks Slipping Late Afternoon	Jan. 17	MT
Sector Update: Health Care Stocks Edge Down Wednesday Afternoon	Jan. 17	MT
Precipio Signs Distribution Deal in Japan, Gets First Order; Shares Rise	Jan. 17	MT
Precipio, Inc. Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan	Jan. 17	CI
Precipio, Inc. Announces Board Changes	Jan. 02	CI
Transcript : Precipio, Inc., Q3 2023 Earnings Call, Nov 20, 2023	Nov. 20
North American Morning Briefing : Stocks Futures -2-	Nov. 20	DJ
Precipio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Precipio, Inc. Reports Unaudited Revenue Results for the Third Quarter of 2023	23-10-18	CI
Precipio Says Lower Product Revenue Needed to Achieve Cash Flow Breakeven	23-09-25	MT
Precipio, Inc. Reports Unaudited Revenue Results for the August 2023	23-09-13	CI
Transcript : Precipio, Inc., Q2 2023 Earnings Call, Aug 17, 2023	23-08-17
Precipio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
End in sight for U.S. insider trading case over healthcare leaks	23-08-01	RE
Precipio, Inc. Announces Unaudited Revenue Results for the Second Quarter of 2023	23-08-01	CI
Precipio's Omnia?? Methodology Enables Diagnosis of MDS with Peripheral Blood Instead of Bone Marrow Biopsy	23-06-14	CI
Precipio, Inc. Enters into Collaboration with Prestigious New York-Based Institution to Develop Revolutionary Brain Tumor Panel Using Hemescreen Technology	23-06-13	CI
Precipio Prices $2 Million Registered Direct Offering, Concurrent Private Placement	23-06-08	MT
Precipio, Inc. announced that it expects to receive $0.014343 million in funding	23-06-06	CI
Precipio, Inc.'s Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology	23-05-22	CI
Transcript : Precipio, Inc., Q1 2023 Earnings Call, May 17, 2023	23-05-17
Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI

Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Companyâs technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its technology enables testing to be completed in one rapid scanning process. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. The Companyâs laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-14 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
PRECIPIO, INC.	+3.15%	9.63M
QUIDELORTHO CORPORATION	-47.48%	2.7B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+1.74%	1.65B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-14.11%	1.44B
BIOTAGE AB	+25.65%	1.25B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-14.73%	967M
CONTEC MEDICAL SYSTEMS CO.,LTD	-23.17%	834M
REVENIO GROUP OYJ	-6.63%	731M
VAREX IMAGING CORPORATION	-17.51%	698M
CELLAVISION AB	+3.07%	483M